NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Newsletters
Advertisement
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HONcode
Security by Verisign

Tetanus


Return to Library

Free Tetanus Articles


Researchers from Medizinische Hochschule Hannover publish findings in neurotoxins



2009 JUL 7 - (NewsRx.com) -- New investigation results, 'Cell entry strategy of clostridial neurotoxins,' are detailed in a study published in Journal of Neurochemistry. According to recent research from Hannover, Germany, "Tetanus neurotoxin and botulinum neurotoxins are the causative agents of tetanus and botulism. They block the release of neurotransmitters from synaptic vesicles in susceptible animals and man and act in nanogram quantities because of their ability to specifically attack motoneurons."

"They developed an ingenious strategy to enter neurons. This involves a concentration step via complex polysialo gangliosides at the plasma membrane and the uptake and ride in recycling synaptic vesicles initiated by binding to a specific protein receptor. Finally, the neurotoxins shut down the synaptic vesicle cycle, which they had misused before to enter their target cells, via specific cleavage of protein core components of the cellular membrane fusion machinery. The uptake of four out of seven known botulinum neurotoxins into synaptic vesicles has been demonstrated to rely on binding to intravesicular segments of the synaptic vesicle proteins synaptotagmin or synaptic vesicle protein 2," wrote T. Binz and colleagues, Medizinische Hochschule Hannover.

The researchers concluded: "This review summarizes the present knowledge about the cell receptor molecules and the mode of toxin-receptor interaction that enables the toxins' sophisticated access to their site of action."

Binz and colleagues published their study in the Journal of Neurochemistry (Cell entry strategy of clostridial neurotoxins. Journal of Neurochemistry, 2009;109(6):1584-95).

For additional information, contact T. Binz, Institut fur Biochemie, Medizinische Hochschule Hannover, Hannover, Germany.

Publisher contact information for the Journal of Neurochemistry is: Blackwell Publishing Inc., 350 Main St., Malden, MA 02148, USA.

Keywords: Germany, Hannover, Neurochemistry, Neurotoxins, Tetanus.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2009, Life Science Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login